...
首页> 外文期刊>Journal of Cancer Treatment and Research >Primary Prostatic Lymphoma Presenting with Features of Prostatism Developed Central Nervous System (CNS) Symptoms During Chemotherapy: A Case Report
【24h】

Primary Prostatic Lymphoma Presenting with Features of Prostatism Developed Central Nervous System (CNS) Symptoms During Chemotherapy: A Case Report

机译:主要前列腺淋巴瘤呈现出在化疗期间出现中枢神经系统(CNS)症状的特征:案例报告

获取原文
           

摘要

Primary lymphoma of prostate is rare representing approximately 0.1% of all non-Hogdk in lymphomas. This type of lymphoma is more common in men with an average age of 60 years old. Dysuria is the most common symptom of prostatic lymphoma, which can lead to misdiagnosis of benign prostatic hyperplasia and adenocarcinoma easily. Besides, PSA was widely considered in the normal range in most patients with prostatic lymphoma, only a few patients showed elevated. We report a case of a 72-year-old primary prostatic diffuse large B-cell lymphoma patient with a significant increasing of PSA, developed Central Nervous System (CNS) symptoms after completing a cycle of R-CHOP therapy. Unfortunately, the patients received R-CHP in combination with high dose immunoglobulin, after a brief relief of CNS symptoms, the similar CNS symptoms returning again later. Involvement of CNS symptoms during therapy represents a serious complication of aggressive lymphoma, which is rare occurring nearly 5% of non-Hodgkin lymphoma and is considered as a high-risk model In conclusions, primary prostatic lymphoma with an increasing of prostatic-specific antigen is a rare case that is easily misdiagnosed. R-CHOP is till the recommended regimen, but other safe and effective alternatives are urgently needed when obvious CNS symptoms occurred during treatment.
机译:前列腺初级淋巴瘤是罕见的淋巴瘤中所有非猪的约0.1%。这种类型的淋巴瘤在平均为60岁的男性中更常见。困难是前列腺淋巴瘤最常见的症状,这可能易于误诊良性前列腺增生和腺癌。此外,PSA在大多数前列腺淋巴瘤患者中被广泛考虑,只有少数患者升高。我们举报了一个72岁的主要前列腺弥漫性大型B细胞淋巴瘤患者,在完成R-Chec疗法的循环后发育中枢神经系统(CNS)症状显着。遗憾的是,患者接受R-CHP与高剂量免疫球蛋白组合,经过短暂的CNS症状,类似的CNS症状再次返回。 CNS症状在治疗过程中涉及侵袭性淋巴瘤的严重并发症,这是罕见的近5%的非霍奇金淋巴瘤,并且在结论中被认为是高风险模型,主要前列腺淋巴瘤随着前列腺特异性抗原的增加一种易误解的罕见案例。 R-Chec是直到推荐的方案,但在治疗期间发生明显的CNS症状时,迫切需要其他安全和有效的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号